USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
〈1079〉 Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products

Proper storage and transportation of finished drug products are critical activities in an integrated supply chain. These finished drug products include but are not limited to temperature-sensitive small molecules, vaccines, biologics, biotechnological products, radiopharmaceuticals, and combination products. With the globalization of the pharmaceutical industry, various individuals and organizations from locations around the world can come into contact with the finished drug product. The storage and transportation processes for a drug product may involve complex movements with differences in documentation, handling requirements, and communication between the various entities throughout the supply chain.

This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!